Supplementary Figure S1 from Plasma MicroRNAs as Novel Biomarkers for Patients with Intraductal Papillary Mucinous Neoplasms of the Pancreas

Flowchart for Statistical Analysis. Circulating miRNAs were evaluated in IPMN cases versus healthy controls and malignant versus benign IPMNs using linear models for microarray data (LIMMA), principal component analysis (PCA), and receiver operating characteristic (ROC) curve analyses, followed by pathway enrichment analyses. We also correlated abundance of plasma miRNAs and tissue miRNAs for cases with both sample types.